Table 2.
Outcomes of Subintimal and Intraluminal Approach After Matching
| Subintimal approach | Intraluminal approach | P value | |
|---|---|---|---|
| Endovascular treatment | |||
| Subintimal approach in successful wire crossing | 47.5% (34.7%–60.2%) | 2.2% (0.3%–4.1%) | <0.001 |
| Subintimal wire passage | 61.0% (48.6%–73.5%) | 36.3% (29.7%–42.9%) | <0.001 |
| Procedure time, min | 82.9 (74.4–92.4) | 78.6 (73.3–84.3) | 0.54 |
| Contrast volume, mL | 82.6 (64.1–106.3) | 88.3 (80.7–96.6) | 0.86 |
| Postoperative outcomes | |||
| Percentage of residual stenosis | 8.5% (1.4%–15.6%) | 6.3% (3.5%–9.1%) | 0.79 |
| Intravascular ultrasound‐derived minimum stent area, mm2 | 16.1 (14.5–17.6) | 14.9 (14.2–15.6) | 0.10 |
| Ankle‐brachial index | 0.90 (0.84–0.95) | 0.90 (0.84–0.95) | 0.96 |
| Perioperative complications | 9.5% (1.3%–17.7%) | 5.6% (1.3%–9.8%) | 0.47 |
| 1‐year clinical outcomes | |||
| Restenosis | 41.0% (21.2%–60.9%) | 43.4% (18.7%–68.1%) | 0.40 |
| All‐cause mortality | 9.4% (1.2%–16.8%) | 8.7% (0.3%–16.5%) | 0.68 |
| Major amputation | 0.0% (0.0%–0.0%) | 0.9% (0.0%–3.5%) | 0.55 |
| Major adverse limb events | 19.1% (6.8%–29.7%) | 15.0% (3.9%–24.7%) | 0.83 |
Data are presented with estimates and 95% CIs.